Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIIb single-arm open-label study of Zalviso for acute postoperative pain
2016-002259-11Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Jul 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sufentanil in acute postoperative pain, sponsored by Grünenthal GmbH. Primary endpoint: Success rate on Patient Global Assessment on postoperative day 2. Started Jul 2016; status: completed.
02
Drugs
sufentanil
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on 2016-002259-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002259-11.